Company Dancann Pharma A/S

Equities

DANCAN

DK0061410487

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 08/05/2024 am IST			5-day change	1st Jan Change
0.07 ^DKK	-4.89%		+16.67%	+133.33%

29/03	Dancann Pharma Plans Up to DKK19 Million Rights Issue	MT
28/02	DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	MT

Dancann Pharma A/S is a Denmark-based pharmaceutical biotechnology company powered by cannabinoids. The Company is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma manufactures and distributes prescription drugs (Rx drugs) and over-the-counter drugs (OTCs), mainly focused on pain patients with alternative needs.

Number of employees: 10

DKK in Million	2021	Weight	2022	Weight	Delta
Cannabinoid-based Drugs and Pharmaceuticals 100.0 %	1	100.0 %	6	100.0 %	+553.09%

DKK in Million	2021	Weight	2022	Weight	Delta
Denmark 100.0 %	1	100.0 %	6	100.0 %	+553.09%

Managers	Title	Age	Since
Jeppe Rasmussen FOU	Founder	29	20/18/20
Peter Søndergaard DFI	Director of Finance/CFO	52	04/23/04
Sarah Mai Lykke-Kjeldsen COO	Chief Operating Officer	37	01/22/01
Jens Markussen PRN	Corporate Officer/Principal	-	09/21/09
Morten Martinsen PRN	Corporate Officer/Principal	36	01/18/01

Members of the board	Title	Age	Since
Carsten Trads CHM	Chairman	69	-
Tue Østergaard BRD	Director/Board Member	47	27/22/27
Jeppe Rasmussen FOU	Founder	29	20/18/20
Alexander Schoeneck BRD	Director/Board Member	41	22/22/22
Christian Carlsen BRD	Director/Board Member	40	29/21/29
Louise Forman BRD	Director/Board Member	-	30/23/30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	141,627,990	20,522,779 ( 14.49 %)	0	14.49 %

DanCann Pharma A/S

Rugvænget 5

6823, Ansager

+45 69 16 03 93

http://www.dancann.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
DANCANN PHARMA A/S	+133.33%	1.68M
VERTEX PHARMACEUTICALS INCORPORATED	+2.97%	108B
REGENERON PHARMACEUTICALS, INC.	+10.21%	105B
ARGENX SE	+1.57%	23.46B
BIONTECH SE	-12.77%	21.72B
GENMAB A/S	-7.05%	18.64B
WUXI APPTEC CO., LTD.	-37.64%	17.45B
BEIGENE, LTD.	-6.50%	17.19B
NEUROCRINE BIOSCIENCES, INC.	+6.00%	13.99B
SAREPTA THERAPEUTICS, INC.	+37.20%	12.53B

Bio Therapeutic Drugs